/CORBF

CORBF Stock - Global Cord Blood Corporation

Q: What is the analyst price target for CORBF?

Analyst price target information is not currently available for CORBF.

Q: What is CORBF's market cap?

Market capitalization information is not currently available for CORBF.

Healthcare|Medical - Diagnostics & Research|OTC

$0.75+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.83

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CORBF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.70

52W High$1.75

52W Low$0.20

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$1.24B	$1.16B	$1.22B	$986.75M	$936.77M
Gross Profit	$1.06B	$980.69M	$1.03B	$800.73M	$755.28M
Gross Margin	85.3%	84.6%	84.5%	81.1%	80.6%
Operating Income	$608.87M	$544.87M	$559.03M	$381.66M	$279.86M
Net Income	$501.06M	$508.25M	$470.72M	$291.12M	$237.10M
Net Margin	40.3%	43.8%	38.5%	29.5%	25.3%
EPS	$4.12	$4.18	$3.87	$2.40	$1.99

Company Overview

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Visit Website

Earnings History & Surprises

CORBF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	Apr 15, 2024	—	—	—	—
Q1 2024	Mar 1, 2024	—	—	—	—
Q4 2023	Nov 14, 2023	—	—	—	—
Q3 2023	Aug 8, 2023	—	—	—	—
Q1 2023	Mar 2, 2023	—	—	—	—

Frequently Asked Questions about CORBF

What is CORBF's current stock price?

Global Cord Blood Corporation (CORBF) is currently trading at $0.75 per share. The stock has moved +0.00% today.

What is the analyst price target for CORBF?

No analyst price targets are currently available for this stock.

What sector is Global Cord Blood Corporation in?

Global Cord Blood Corporation operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.

What is CORBF's market cap?

Global Cord Blood Corporation has a market capitalization of $0.10 billion, making it a small-cap company.

Does CORBF pay dividends?

No, Global Cord Blood Corporation does not currently pay a dividend to shareholders.